ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available

March 18, 1994

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

January 8, 1988

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

Funding Opportunities: RFAs For Mouse Models Consortium, Urology Research Centers

August 7, 1998

Isis 3521 Gets Fast-track Status For FDA Review.

December 1, 2000